Omada Health (NASDAQ:OMDA) Stock Price Up 4.5% – Here’s Why

Omada Health, Inc. (NASDAQ:OMDA)’s stock price traded up 4.5% on Wednesday . The company traded as high as $16.07 and last traded at $15.97. 162,508 shares traded hands during trading, a decline of 76% from the average session volume of 675,594 shares. The stock had previously closed at $15.28.

Wall Street Analyst Weigh In

OMDA has been the topic of a number of recent research reports. Weiss Ratings reissued a “sell (d)” rating on shares of Omada Health in a report on Wednesday, October 8th. Barclays upped their price objective on Omada Health from $28.00 to $29.00 and gave the stock an “overweight” rating in a research note on Friday, November 7th. Baird R W raised shares of Omada Health to a “hold” rating in a report on Friday, September 5th. Evercore ISI increased their price objective on shares of Omada Health from $27.00 to $28.00 and gave the stock an “outperform” rating in a report on Friday, November 7th. Finally, BMO Capital Markets began coverage on shares of Omada Health in a research note on Thursday, November 13th. They issued an “outperform” rating and a $27.00 price target on the stock. Eight investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $27.11.

Omada Health Price Performance

The stock has a fifty day moving average price of $20.08.

Institutional Investors Weigh In On Omada Health

Several large investors have recently modified their holdings of the stock. Raymond James Financial Inc. acquired a new stake in shares of Omada Health during the second quarter worth $32,000. Strs Ohio acquired a new stake in shares of Omada Health during the third quarter valued at approximately $38,000. Rakuten Investment Management Inc. acquired a new position in Omada Health in the 3rd quarter worth approximately $49,000. JPMorgan Chase & Co. acquired a new stake in shares of Omada Health in the third quarter worth $82,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in Omada Health during the 3rd quarter worth about $95,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.